The story has been updated to include comments from Qiagen's conference call.

NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Monday that its revenues rose 2 percent year over year as growth in molecular diagnostics and applied testing offset weakness in pharma and academia.

Separately, Qiagen said that it acquired genomic data software firm Ingenuity Systems for $105 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.